Diagnosis of frontotemporal lobar degeneration (FTLD) currently relies on physical examination, cognitive assessments, laboratory tests, brain imaging, and patient history. Given the complex and overlapping symptomology of FTLD disorders (which includes bvFTD, ALS-FTD, PSP, CBS, and some PPA disorders), accurate diagnosis is difficult, time-intensive, and error-prone; as a result, accurate assessments often rely on the expertise of leading FTLD clinicians based at specialized centers.
Biomarkers are urgently needed as objective tools to improve access to diagnosis by screening individuals in need of evaluation by a neurologist, enabling accurate and timely diagnosis, and identifying pathological types to inform clinical care and prognosis.
With support from the Holloway Family Fund, AFTD has partnered with the Alzheimer's Association to provide funding to researchers with promising, relevant research poised to advance our understanding of FTLD biomarkers. By supporting researchers, we and our partners hope to pave the path to more accurate and timely diagnosis for families affected by FTD.
This funding opportunity is open to investigators worldwide at:
Collaborative arrangements, e.g., between academia and industry, senior and early-career researchers, or ALS and FTD researchers, are encouraged.
Postdoctoral researchers cannot apply as the lead Principal Investigator but can be co-PIs on a project team.
Sponsor Institute/Organizations: Association for Frontotemporal Degeneration
Sponsor Type:
Address: 2700 Horizon Drive, Suite 120 King of Prussia, PA 19406
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
May 09, 2025
May 09, 2025
$700,000
Affiliation: Association for Frontotemporal Degeneration
Address: 2700 Horizon Drive, Suite 120 King of Prussia, PA 19406
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.